Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with radioligand intensification despite early on-treatment score fluctuations. FACT-P ...
The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...
Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...
India, March 17 -- Can the human body produce vitamin B2? No, the human body cannot produce vitamin B2 (riboflavin) on its own. Without enough riboflavin, the body cannot make the molecules needed to ...
Men receiving treatment for prostate cancer often face challenges that extend well beyond the disease itself. A new study led ...
Investigators evaluated patient-reported outcomes and tolerability of capivasertib plus abiterone in PTEN-deficient metastatic hormone-sensitive prostate cancer.
This illustration shows targeted alpha therapy, in which actinium-225 is linked to a targeting molecule that binds to a ...
When Janice Johnson went to the hospital for what she thought was food poisoning, she had no idea it would lead to a cancer ...
Lancs Live on MSN
Fidgeting and laundry change could be signs of a health problem
Partners and family members could be the first to notice ...
A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results